Anzeige
Mehr »
Mittwoch, 25.06.2025 - Börsentäglich über 12.000 News
TAO +1.800?%, SBAR +85?%, CYK +280?% - jetzt startet KORA auf Unternehmensebene durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
10:46FDA approves Sanofi and Regeneron's Dupixent for bullous pemphigoid
DiPharmaceutical Technology Excellence Awards 2025: i3 Membrane
DiOvercoming technical challenges in gene therapy product fill-finish operations
DiZambon gains Chinese regulatory authority approval for Fluimucil IV
DiNavamedic signs agreement to acquire dne pharma
DiHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
DiFDA genAI reviews hinge on clarity of dossiers
DiFDA approves AstraZeneca and Daiichi Sankyo's Datroway for NSCLC
MoBayer's Eylea market grip set to slip as Alvotech biosimilar closes in
MoHarbour BioMed partners Otsuka on new T-cell therapy
MoBridging the gap: A comprehensive approach to social determinants of health
MoEC approves argenx's efgartigimod alfa for CIDP treatment
MoFrom discovery to delivery: making therapies reach patients faster
FrMadrigal poised to enter European MASH market after CHMP endorsement
FrLondon Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape
FrPodcast: Uses of blockchain in healthcare
FrNovartis' ribociclib approved in Canada for early breast cancer
FrFDA cell and gene therapy director exit increases 'volatility' for sector
FrNSW government invests $13.39m in life-changing therapies
FrDoH - Abu Dhabi and Sanofi link for vaccine development
DoCNS innovator oligonucleotide licensing value up 339% from £2bn in 2024
DoUK and US governments pursue contrasting vaccine strategies
DoActio gains $66m to advance small molecule therapeutics pipeline
DoBioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals
DoEli Lilly and Eisai's Alzheimer's drugs denied NHS use due to high costs